Study of Antibiotic Utilization Measures and Control of ESBLs in China

Antibiotic-resistant Bacterial Infection of Hepatic Patients

NCT03855709 ·Status: UNKNOWN

Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae

NCT04903886 ·Status: UNKNOWN

A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli

NCT00724919 ·Status: COMPLETED

Factors Influencing the Fecal Relative Abundance of ESBL-producing Enterobacteriaceae in Intensive Care (BLSE-REA).

NCT04190316 ·Status: UNKNOWN ·Phase: NA

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis

NCT01961206 ·Status: COMPLETED

Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria

NCT07345923 ·Status: RECRUITING

Antimicrobial Resistance Rate In Escherichia Coli And Klebsiella Pneumonia : A Retrospective Study

NCT04196387 ·Status: COMPLETED

Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital

NCT07255443 ·Status: NOT_YET_RECRUITING

WGS-guided Tracking and Infection Control Measures of CRKP

NCT04413305 ·Status: UNKNOWN ·Phase: NA

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

NCT00363220 ·Status: COMPLETED

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection

NCT04131569 ·Status: UNKNOWN

Detection of Anaerobes in Different Clinicalsamples

NCT03266341 ·Status: UNKNOWN

Study Evaluating the Etiology of Intra-Abdominal Infections

NCT00244088 ·Status: COMPLETED

Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals

NCT06252428 ·Status: COMPLETED

Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

NCT03338738 ·Status: COMPLETED ·Phase: NA

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?

NCT04699981 ·Status: UNKNOWN ·Phase: NA

Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU

NCT05833282 ·Status: UNKNOWN

Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change

NCT01392118 ·Status: UNKNOWN

Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae

NCT01138566 ·Status: UNKNOWN

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

NCT00404625 ·Status: UNKNOWN

Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares

NCT00976638 ·Status: COMPLETED ·Phase: NA

Urinary Tract Infections Caused by ESBL-producing Enterobacteria

NCT03501901 ·Status: COMPLETED

Optimization Management Study of Community Urinary Tract Infections Spectrum

NCT03655548 ·Status: COMPLETED

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

NCT02852902 ·Status: COMPLETED

Correlation Analysis of Xpert Carba-R Detection of Non-colonized CRE in BALF and Rectal Swabs From Patients With LRTI

NCT06636890 ·Status: ENROLLING_BY_INVITATION